Fundraising Fox

Syenex

Evanston, US · Founded 2022 · Delaware corporation · 3 known investors

syenex.com ↗

Syenex provides cell delivery technologies and contract development services for therapeutic cell engineering, serving biopharmaceutical companies developing cell-based therapies. The company integrates cell engineering and delivery capabilities with regulatory support for clinical development.

BiotechDeep TechMedical Devicesin /syenex@syenex

Founders & leadership

JD
John D. RosanelliExecutive Officer, Director

Investors · 3

AlleyCorpNew York · $1M – $5M
Alley Robotics VenturesreportedCohasset · $500K – $2Mvia Abe Murray · inferred
KdT VenturesreportedAustin · $500K – $3M

Reported raises · per SEC filings

Form D private placements
▶$8.7MraisedJan 2025 · 18 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • John D. RosanelliExecutive Officer, Director
Offering amount
$8.7M
Amount sold
$8.7M
First sale
Jan 2025
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedSep 2022 · 14 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • John D. RosanelliExecutive Officer, Director
Offering amount
$5M
Amount sold
$5M
First sale
Jun 2022
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.